A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101)

A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)

International Journal of Clinical Oncology ◽

10.1007/s10147-015-0895-3 ◽

2015 ◽

Vol 21 (2) ◽

pp. 335-343 ◽

Cited By ~ 6

Author(s):

Yutaka Ogata ◽

◽

Mototsugu Shimokawa ◽

Takaho Tanaka ◽

Yasunori Emi ◽

...

Keyword(s):

Colorectal Cancer ◽

Prospective Study ◽

Japanese Patients ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Abstract 3888: Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048).

10.1158/1538-7445.am2015-3888 ◽

2015 ◽

Author(s):

Suzan McNamara ◽

Ryan Morin ◽

Mathilde Couëtoux du Tertre ◽

Rosemary McCloskey ◽

Rebecca Johnston ◽

...

Keyword(s):

Colorectal Cancer ◽

Prospective Study ◽

Molecular Mechanisms ◽

Molecular Profiling ◽

First Line ◽

Therapeutic Implications ◽

First Line Therapy ◽

Line Therapy ◽

Clinical Resistance ◽

Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study

Clinics and Research in Hepatology and Gastroenterology ◽

10.1016/j.clinre.2012.10.014 ◽

2013 ◽

Vol 37 (5) ◽

pp. 527-529 ◽

Cited By ~ 5

Author(s):

Bilal Ergül ◽

Erdem Koçak ◽

Adnan Taş ◽

Levent Filik ◽

Seyfettin Köklü

Keyword(s):

Prospective Study ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

H Pylori ◽

Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyq069 ◽

2010 ◽

Vol 40 (10) ◽

pp. 913-920 ◽

Cited By ~ 29

Author(s):

T. Doi ◽

N. Boku ◽

K. Kato ◽

Y. Komatsu ◽

K. Yamaguchi ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Japanese Patients ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients

British Journal of Dermatology ◽

10.1111/j.1365-2133.2009.09601.x ◽

2009 ◽

Vol 162 (4) ◽

pp. 854-859 ◽

Cited By ~ 28

Author(s):

L. Brambilla ◽

M. Bellinvia ◽

A. Tourlaki ◽

B. Scoppio ◽

F. Gaiani ◽

...

Keyword(s):

Prospective Study ◽

Kaposi Sarcoma ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Nodular Lesions ◽

Classic Kaposi Sarcoma ◽

Efficacy and safety findings from a phase II study of capecitabine (X) as first-line therapy in Japanese patients (pts) with advanced/metastatic colorectal cancer (MCRC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3693 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3693-3693 ◽

Cited By ~ 1

Author(s):

K. Shirao ◽

T. Doi ◽

K. Hatake ◽

Y. Arai ◽

K. Yamaguchi ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer

10.1158/1538-7445.am2012-3389 ◽

2012 ◽

Cited By ~ 1

Author(s):

Zuanel Diaz ◽

Adriana Aguilar-Mahecha ◽

Mark Basik ◽

Dimcho Bachvarov ◽

Luc Bélanger ◽

...

Keyword(s):

Colorectal Cancer ◽

Prospective Study ◽

Optimal Conditions ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Clinical Resistance ◽

Liver Biopsies ◽

Multicenter Prospective Study ◽

Metastatic Liver

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyt127 ◽

2013 ◽

Vol 43 (11) ◽

pp. 1080-1086 ◽

Cited By ~ 17

Author(s):

T. Nishina ◽

Y. Takano ◽

T. Denda ◽

H. Yasui ◽

K. Takeda ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Study ◽

Cancer Patients ◽

Phase Ii ◽

Recurrent Colorectal Cancer ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase Ii Clinical Study ◽

Colorectal Cancer Patients

The Efficacy of Two-Week Quadruple First-Line Therapy with Bismuth, Lansoprazole, Amoxicillin, Clarithromycin onHelicobacter pyloriEradication: A Prospective Study

Helicobacter ◽

10.1111/hel.12086 ◽

2013 ◽

Vol 18 (6) ◽

pp. 454-458 ◽

Cited By ~ 13

Author(s):

Bilal Ergül ◽

Zeynal Doğan ◽

Murat Sarikaya ◽

Levent Filik

Keyword(s):

Prospective Study ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

698 PUBLICATION Efficacy and safety findings from a phase II study of capecitabine (X) as first-line therapy in Japanese patients (pts) with metastatic colorectal cancer (MCRC): comparison with published Western data

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80993-0 ◽

2005 ◽

Vol 3 (2) ◽

pp. 198

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Line Therapy